IDEXX Laboratories, Inc. (IDXX)
USD 410.76
(-3.82%)
USD 410.76
(-3.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.09 Billion USD | -1.15% |
| 2022 | 1.1 Billion USD | 15.48% |
| 2021 | 957.4 Million USD | 9.23% |
| 2020 | 876.51 Million USD | 7.85% |
| 2019 | 812.7 Million USD | 8.33% |
| 2018 | 750.2 Million USD | 9.62% |
| 2017 | 684.35 Million USD | 9.46% |
| 2016 | 625.19 Million USD | 7.4% |
| 2015 | 582.14 Million USD | 4.73% |
| 2014 | 555.86 Million USD | 13.59% |
| 2013 | 489.35 Million USD | 12.09% |
| 2012 | 436.58 Million USD | 6.41% |
| 2011 | 410.28 Million USD | 9.48% |
| 2010 | 374.74 Million USD | 6.97% |
| 2009 | 350.31 Million USD | -1.96% |
| 2008 | 357.31 Million USD | 9.16% |
| 2007 | 327.33 Million USD | 30.11% |
| 2006 | 251.59 Million USD | 21.21% |
| 2005 | 207.56 Million USD | 21.4% |
| 2004 | 170.98 Million USD | 14.05% |
| 2003 | 149.91 Million USD | 18.13% |
| 2002 | 126.91 Million USD | 0.1% |
| 2001 | 126.77 Million USD | -11.59% |
| 2000 | 143.4 Million USD | -0.76% |
| 1999 | 144.5 Million USD | -2.76% |
| 1998 | 148.6 Million USD | 0.68% |
| 1997 | 147.6 Million USD | 25.3% |
| 1996 | 117.8 Million USD | 46.34% |
| 1995 | 80.5 Million USD | 46.63% |
| 1994 | 54.9 Million USD | 22.0% |
| 1993 | 45 Million USD | 45.63% |
| 1992 | 30.9 Million USD | 91.93% |
| 1991 | 16.1 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 294.11 Million USD | 4.72% |
| 2024 Q2 | 355.35 Million USD | 20.82% |
| 2024 Q3 | 292.14 Million USD | -17.79% |
| 2023 Q3 | 272.69 Million USD | -1.45% |
| 2023 Q2 | 276.7 Million USD | 5.38% |
| 2023 Q1 | 262.57 Million USD | 1.61% |
| 2023 FY | 1.09 Billion USD | -1.15% |
| 2023 Q4 | 280.86 Million USD | 2.99% |
| 2022 Q3 | 261.79 Million USD | -21.84% |
| 2022 Q1 | 250.4 Million USD | -2.65% |
| 2022 Q2 | 334.96 Million USD | 33.77% |
| 2022 FY | 1.1 Billion USD | 15.48% |
| 2022 Q4 | 258.4 Million USD | -1.3% |
| 2021 Q4 | 257.23 Million USD | 4.16% |
| 2021 Q1 | 223.16 Million USD | -0.56% |
| 2021 Q2 | 230.05 Million USD | 3.09% |
| 2021 Q3 | 246.95 Million USD | 7.35% |
| 2021 FY | 957.4 Million USD | 9.23% |
| 2020 Q4 | 224.4 Million USD | -10.51% |
| 2020 Q1 | 215.26 Million USD | -0.12% |
| 2020 FY | 876.51 Million USD | 7.85% |
| 2020 Q2 | 186.09 Million USD | -13.55% |
| 2020 Q3 | 250.75 Million USD | 34.74% |
| 2019 Q1 | 198.45 Million USD | 7.27% |
| 2019 FY | 812.7 Million USD | 8.33% |
| 2019 Q4 | 215.51 Million USD | 5.05% |
| 2019 Q3 | 205.14 Million USD | 5.98% |
| 2019 Q2 | 193.57 Million USD | -2.46% |
| 2018 Q4 | 185.01 Million USD | -1.74% |
| 2018 FY | 750.2 Million USD | 9.62% |
| 2018 Q2 | 186.84 Million USD | -1.69% |
| 2018 Q1 | 190.05 Million USD | 8.81% |
| 2018 Q3 | 188.29 Million USD | 0.77% |
| 2017 Q1 | 165.94 Million USD | 5.83% |
| 2017 FY | 684.35 Million USD | 9.46% |
| 2017 Q4 | 174.66 Million USD | 0.62% |
| 2017 Q2 | 170.15 Million USD | 2.53% |
| 2017 Q3 | 173.58 Million USD | 2.02% |
| 2016 Q1 | 153.74 Million USD | 1.96% |
| 2016 FY | 625.19 Million USD | 7.4% |
| 2016 Q4 | 156.8 Million USD | -0.93% |
| 2016 Q3 | 158.27 Million USD | 1.21% |
| 2016 Q2 | 156.38 Million USD | 1.72% |
| 2015 Q3 | 144.16 Million USD | -0.2% |
| 2015 FY | 582.14 Million USD | 4.73% |
| 2015 Q1 | 142.74 Million USD | -3.14% |
| 2015 Q2 | 144.45 Million USD | 1.2% |
| 2015 Q4 | 150.78 Million USD | 4.59% |
| 2014 Q3 | 141.14 Million USD | 4.32% |
| 2014 Q1 | 132.05 Million USD | 3.7% |
| 2014 FY | 555.86 Million USD | 13.59% |
| 2014 Q2 | 135.29 Million USD | 2.46% |
| 2014 Q4 | 147.36 Million USD | 4.4% |
| 2013 Q1 | 122.78 Million USD | 16.25% |
| 2013 FY | 489.35 Million USD | 12.09% |
| 2013 Q4 | 127.33 Million USD | 5.85% |
| 2013 Q3 | 120.29 Million USD | 1.15% |
| 2013 Q2 | 118.93 Million USD | -3.14% |
| 2012 Q3 | 107.72 Million USD | -1.06% |
| 2012 Q2 | 108.87 Million USD | -4.8% |
| 2012 Q1 | 114.36 Million USD | 10.41% |
| 2012 FY | 436.58 Million USD | 6.41% |
| 2012 Q4 | 105.62 Million USD | -1.95% |
| 2011 Q4 | 103.58 Million USD | 0.99% |
| 2011 FY | 410.28 Million USD | 9.48% |
| 2011 Q1 | 101.39 Million USD | 7.9% |
| 2011 Q2 | 102.73 Million USD | 1.32% |
| 2011 Q3 | 102.57 Million USD | -0.16% |
| 2010 FY | 374.74 Million USD | 6.97% |
| 2010 Q4 | 93.96 Million USD | 1.7% |
| 2010 Q3 | 92.39 Million USD | -2.18% |
| 2010 Q2 | 94.44 Million USD | 0.55% |
| 2010 Q1 | 93.93 Million USD | 5.8% |
| 2009 FY | 350.31 Million USD | -1.96% |
| 2009 Q3 | 86.27 Million USD | -3.35% |
| 2009 Q2 | 89.26 Million USD | 3.81% |
| 2009 Q1 | 85.99 Million USD | 1.56% |
| 2009 Q4 | 88.78 Million USD | 2.91% |
| 2008 FY | 357.31 Million USD | 9.16% |
| 2008 Q3 | 89.15 Million USD | -3.48% |
| 2008 Q2 | 92.36 Million USD | 1.37% |
| 2008 Q4 | 84.67 Million USD | -5.03% |
| 2008 Q1 | 91.11 Million USD | 6.57% |
| 2007 Q3 | 82.38 Million USD | 0.77% |
| 2007 Q2 | 81.75 Million USD | 5.21% |
| 2007 Q1 | 77.7 Million USD | 16.32% |
| 2007 FY | 327.33 Million USD | 30.11% |
| 2007 Q4 | 85.5 Million USD | 3.79% |
| 2006 FY | 251.59 Million USD | 21.21% |
| 2006 Q4 | 66.79 Million USD | 4.8% |
| 2006 Q3 | 63.73 Million USD | 2.79% |
| 2006 Q2 | 62.01 Million USD | 5.01% |
| 2006 Q1 | 59.05 Million USD | 7.89% |
| 2005 Q1 | 49.94 Million USD | 9.44% |
| 2005 FY | 207.56 Million USD | 21.4% |
| 2005 Q4 | 54.73 Million USD | 6.89% |
| 2005 Q3 | 51.2 Million USD | -0.93% |
| 2005 Q2 | 51.68 Million USD | 3.5% |
| 2004 Q2 | 40.94 Million USD | -1.91% |
| 2004 Q3 | 42.65 Million USD | 4.17% |
| 2004 Q4 | 45.63 Million USD | 6.99% |
| 2004 FY | 170.98 Million USD | 14.05% |
| 2004 Q1 | 41.74 Million USD | -6.74% |
| 2003 Q2 | 35.33 Million USD | 3.89% |
| 2003 Q1 | 34.01 Million USD | 11.49% |
| 2003 Q3 | 35.8 Million USD | 1.32% |
| 2003 Q4 | 44.76 Million USD | 25.02% |
| 2003 FY | 149.91 Million USD | 18.13% |
| 2002 Q4 | 30.5 Million USD | -6.01% |
| 2002 Q3 | 32.46 Million USD | 4.05% |
| 2002 Q2 | 31.19 Million USD | -3.04% |
| 2002 Q1 | 32.17 Million USD | 12.25% |
| 2002 FY | 126.91 Million USD | 0.1% |
| 2001 FY | 126.77 Million USD | -11.59% |
| 2001 Q2 | 34.46 Million USD | 5.47% |
| 2001 Q3 | 30.97 Million USD | -10.13% |
| 2001 Q4 | 28.66 Million USD | -7.46% |
| 2001 Q1 | 32.67 Million USD | -3.75% |
| 2000 Q2 | 37.66 Million USD | 0.11% |
| 2000 FY | 143.4 Million USD | -0.76% |
| 2000 Q4 | 33.94 Million USD | -0.64% |
| 2000 Q3 | 34.16 Million USD | -9.29% |
| 2000 Q1 | 37.62 Million USD | 8.43% |
| 1999 Q2 | 37.2 Million USD | -4.12% |
| 1999 Q3 | 33.7 Million USD | -9.41% |
| 1999 Q4 | 34.7 Million USD | 2.97% |
| 1999 FY | 144.5 Million USD | -2.76% |
| 1999 Q1 | 38.8 Million USD | 7.48% |
| 1998 Q2 | 37.6 Million USD | -3.34% |
| 1998 Q3 | 35.9 Million USD | -4.52% |
| 1998 Q1 | 38.9 Million USD | 5.14% |
| 1998 FY | 148.6 Million USD | 0.68% |
| 1998 Q4 | 36.1 Million USD | 0.56% |
| 1997 FY | 147.6 Million USD | 25.3% |
| 1997 Q1 | 35 Million USD | 4.48% |
| 1997 Q2 | 37.9 Million USD | 8.29% |
| 1997 Q3 | 37.6 Million USD | -0.79% |
| 1997 Q4 | 37 Million USD | -1.6% |
| 1996 FY | 117.8 Million USD | 46.34% |
| 1996 Q2 | 27.6 Million USD | 8.66% |
| 1996 Q1 | 25.4 Million USD | 17.05% |
| 1996 Q4 | 33.5 Million USD | 7.37% |
| 1996 Q3 | 31.2 Million USD | 13.04% |
| 1995 Q3 | 20.2 Million USD | -0.98% |
| 1995 Q4 | 21.7 Million USD | 7.43% |
| 1995 FY | 80.5 Million USD | 46.63% |
| 1995 Q1 | 17.9 Million USD | 19.33% |
| 1995 Q2 | 20.4 Million USD | 13.97% |
| 1994 Q2 | 13.6 Million USD | 6.25% |
| 1994 Q3 | 13.6 Million USD | 0.0% |
| 1994 Q4 | 15 Million USD | 10.29% |
| 1994 FY | 54.9 Million USD | 22.0% |
| 1994 Q1 | 12.8 Million USD | 16.36% |
| 1993 FY | 45 Million USD | 45.63% |
| 1993 Q2 | 11.7 Million USD | 20.62% |
| 1993 Q4 | 11 Million USD | -6.78% |
| 1993 Q1 | 9.7 Million USD | 18.29% |
| 1993 Q3 | 11.8 Million USD | 0.85% |
| 1992 Q1 | 6.5 Million USD | 32.65% |
| 1992 Q4 | 8.2 Million USD | 1.23% |
| 1992 Q3 | 8.1 Million USD | 0.0% |
| 1992 FY | 30.9 Million USD | 91.93% |
| 1992 Q2 | 8.1 Million USD | 24.62% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | 16.1 Million USD | 0.0% |
| 1991 Q3 | 3.9 Million USD | 0.0% |
| 1991 Q2 | 3.9 Million USD | 0.0% |
| 1991 Q4 | 4.9 Million USD | 25.64% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -633.485% |
| Prenetics Global Limited | 60.73 Million USD | -1699.314% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -6616.089% |
| CareDx, Inc | 277.76 Million USD | -293.437% |
| Exact Sciences Corporation | 2.06 Billion USD | 46.963% |
| Exagen Inc. | 52.29 Million USD | -1989.844% |
| Inotiv, Inc. | 246.9 Million USD | -342.62% |
| Guardant Health, Inc. | 901.62 Million USD | -21.209% |
| Biodesix, Inc. | 77.41 Million USD | -1311.594% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -27756.692% |
| Precipio, Inc. | 13.63 Million USD | -7913.213% |
| iSpecimen Inc. | 16.27 Million USD | -6613.917% |
| Natera, Inc. | 938.98 Million USD | -16.385% |
| Aspira Women's Health Inc. | 24.11 Million USD | -4431.981% |
| Standard BioTools Inc. | 113.48 Million USD | -862.95% |
| 23andMe Holding Co. | 420.73 Million USD | -159.747% |
| Castle Biosciences, Inc. | 242.78 Million USD | -350.131% |
| Personalis, Inc. | 128.14 Million USD | -752.823% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -888.774% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -6528.619% |
| OpGen, Inc. | 30.65 Million USD | -3464.627% |
| T2 Biosystems, Inc. | 41.49 Million USD | -2533.735% |
| Myriad Genetics, Inc. | 600.1 Million USD | -82.11% |
| ICON Public Limited Company | 755.64 Million USD | -44.624% |
| NeoGenomics, Inc. | 341.25 Million USD | -220.245% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -6616.089% |
| RadNet, Inc. | 268.87 Million USD | -306.444% |
| MDxHealth SA | 71.25 Million USD | -1433.684% |
| Psychemedics Corporation | 11.33 Million USD | -9542.156% |
| Illumina, Inc. | 3.81 Billion USD | 71.339% |
| Check-Cap Ltd. | 19.28 Million USD | -5566.21% |
| Twist Bioscience Corporation | 354.18 Million USD | -208.556% |
| DarioHealth Corp. | 62.17 Million USD | -1657.744% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -535.721% |
| Sera Prognostics, Inc. | 39.91 Million USD | -2637.786% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -10287.506% |
| OPKO Health, Inc. | 574.68 Million USD | -90.163% |
| Medpace Holdings, Inc. | 187.68 Million USD | -482.29% |
| Neogen Corporation | 405.23 Million USD | -169.68% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -9233.51% |
| Prenetics Global Limited | 60.73 Million USD | -1699.314% |
| Mainz Biomed B.V. | 27.15 Million USD | -3924.557% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -12368.472% |
| Trinity Biotech plc | 46.49 Million USD | -2250.451% |
| Neuronetics, Inc. | 82.25 Million USD | -1228.538% |
| Sotera Health Company | 300.46 Million USD | -263.716% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -12368.472% |